NCT01021748 2018-08-07A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)Merck Sharp & Dohme LLCPhase 1 Completed63 enrolled 17 charts
NCT02063230 2016-07-21To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsAstraZenecaPhase 1 Completed32 enrolled 12 charts
NCT02056392 2015-11-09To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male VolunteersAstraZenecaPhase 1 Completed54 enrolled 31 charts